1. Home
  2. RVT vs NBTX Comparison

RVT vs NBTX Comparison

Compare RVT & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Royce Value Trust Inc.

RVT

Royce Value Trust Inc.

HOLD

Current Price

$18.64

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$41.70

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVT
NBTX
Founded
1986
2003
Country
United States
France
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.3B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
RVT
NBTX
Price
$18.64
$41.70
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
185.8K
152.7K
Earning Date
01-01-0001
03-31-2026
Dividend Yield
7.32%
N/A
EPS Growth
N/A
N/A
EPS
2.95
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$58.17
Revenue Next Year
N/A
N/A
P/E Ratio
$6.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.97
$8.03
52 Week High
$19.12
$57.14

Technical Indicators

Market Signals
Indicator
RVT
NBTX
Relative Strength Index (RSI) 56.29 56.94
Support Level $17.70 $30.74
Resistance Level $19.12 $45.74
Average True Range (ATR) 0.20 2.59
MACD -0.02 0.38
Stochastic Oscillator 43.86 71.00

Price Performance

Historical Comparison
RVT
NBTX

About RVT Royce Value Trust Inc.

Royce Small-Cap Trust Inc is a diversified closed-end investment company that invests in equity securities of small-cap companies. The company portfolio includes sectors such as Industrials, Financials, Information Technology, Health Care, and Consumer Discretionary.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: